Background: Intracranial hemorrhage (ICH) is a severe and potentially life-threatening condition, often associated with the use of anticoagulant medications. The balance between the therapeutic benefits of anticoagulation and the risk of hemorrhagic complications remains a critical concern. Objectives: This retrospective study of 10 years from January 2013 to December 2023 aims to explore the association between anticoagulant use and the incidence of intracranial hemorrhage, to identify potential risk factors, and to contribute to the optimization of anticoagulant therapy. Methods: We conducted a cross-sectional analysis of 100 patients who were admitted to Apex Superspeciality Hospital with a diagnosis of ICH. Data on anticoagulant use, patient demographics, medical history, and clinical outcomes were collected and analyzed. Results: Preliminary analyses suggest a significant association between anticoagulant use and the risk of ICH. Detailed results will discuss the extent of this association, controlling for confounding factors such as age, comorbidities, and type of anticoagulant. Conclusions: Understanding the relationship between anticoagulant use and ICH risk is crucial for managing anticoagulation therapy and mitigating hemorrhagic complications. Our findings aim to inform clinical guidelines and patient management strategies.